TY - JOUR AU - Steenbergen, J. N. AU - Alder, J. AU - Thorne, G. M. AU - Tally, F. P. PY - 2005 DA - 2005// TI - Daptomycin: a lipopeptide antibiotic for the treatment of serious gram-positive infections JO - J Antimicrob Chemother VL - 55 UR - https://doi.org/10.1093/jac/dkh546 DO - 10.1093/jac/dkh546 ID - Steenbergen2005 ER - TY - JOUR AU - Liu, C. AU - Bayer, A. AU - Cosgrove, S. E. AU - Daum, R. S. AU - Fridkin, S. K. AU - Gorwitz, R. J. PY - 2011 DA - 2011// TI - Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus Aureus infections in adults and children JO - Clin Infect Dis VL - 52 UR - https://doi.org/10.1093/cid/ciq146 DO - 10.1093/cid/ciq146 ID - Liu2011 ER - TY - JOUR AU - Webster, P. S. AU - Oleson, F. B. AU - Paterson, D. L. AU - Arkin, C. F. AU - Mangili, A. AU - Craven, D. E. PY - 2008 DA - 2008// TI - Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/international normalized ratio results JO - Blood Coagul Fibrinolysis VL - 19 UR - https://doi.org/10.1097/MBC.0b013e3282f10275 DO - 10.1097/MBC.0b013e3282f10275 ID - Webster2008 ER - TY - JOUR AU - van den Besselaar, A. M. H. P. AU - Breukink, E. AU - Koorengevel, M. C. PY - 2010 DA - 2010// TI - Phosphatidylglycerol and daptomycin synergistically inhibit tissue factor-induced coagulation in the prothrombin time test JO - J Thromb Haemost VL - 8 UR - https://doi.org/10.1111/j.1538-7836.2010.03868.x DO - 10.1111/j.1538-7836.2010.03868.x ID - van den Besselaar2010 ER - TY - JOUR AU - Yamada, T. AU - Kato, R. AU - Oda, K. AU - Tanaka, H. AU - Suzuki, K. AU - Ijiri, Y. PY - 2016 DA - 2016// TI - False prolongation of prothrombin time in the presence of a high blood concentration of daptomycin JO - Basic Clin Pharmacol Toxicol VL - 119 UR - https://doi.org/10.1111/bcpt.12597 DO - 10.1111/bcpt.12597 ID - Yamada2016 ER - TY - STD TI - Merck & Co., Inc. (2017) Drug information: CUBICINĀ® (daptomycin for injection). https://www.merck.com/product/usa/pi_circulars/c/cubicin/cubicin_pi.pdf. Accessed 19 May 2017. UR - https://www.merck.com/product/usa/pi_circulars/c/cubicin/cubicin_pi.pdf ID - ref6 ER - TY - JOUR AU - Saito, M. AU - Hatakeyama, S. AU - Hashimoto, H. AU - Suzuki, T. AU - Jubishi, D. AU - Kaneko, M. PY - 2017 DA - 2017// TI - Dose-dependent artificial prolongation of prothrombin time by interaction between daptomycin and test reagents in patients receiving warfarin: a prospective in vivo clinical study JO - Ann Clin Microbiol Antimicrob VL - 16 UR - https://doi.org/10.1186/s12941-017-0203-3 DO - 10.1186/s12941-017-0203-3 ID - Saito2017 ER - TY - JOUR AU - Benvenuto, M. AU - Benziger, D. P. AU - Yankelev, S. AU - Vigliani, G. PY - 2006 DA - 2006// TI - Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.00247-06 DO - 10.1128/AAC.00247-06 ID - Benvenuto2006 ER - TY - JOUR AU - Baumann Kreuziger, L. M. AU - Kim, B. AU - Wieselthaler, G. M. PY - 2015 DA - 2015// TI - Antithrombotic therapy for left ventricular assist devices in adults: a systematic review JO - J Thromb Haemost VL - 13 UR - https://doi.org/10.1111/jth.12948 DO - 10.1111/jth.12948 ID - Baumann Kreuziger2015 ER - TY - JOUR AU - Whitlock, R. P. AU - Sun, J. C. AU - Fremes, S. E. AU - Rubens, F. D. AU - Teoh, K. H. PY - 2012 DA - 2012// TI - Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines JO - Chest VL - 141 UR - https://doi.org/10.1378/chest.11-2305 DO - 10.1378/chest.11-2305 ID - Whitlock2012 ER -